The Acquisition Of St. Jude By Abbott Labs Given New FTC Conditions

By: via Benzinga
In an effort to preserve competition in the cardiac device market, Abbott Laboratories (NYSE: ABT) will comply with the Federal Trade ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.